Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2007

Mar 2, 2007

30339_dirs_2007-03-02_122c5345-388a-4e5c-b463-82c5f2be1cae.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2007-02-28

Reporting Person: HARGESHEIMER ROBERT S (President - The Tech Group)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-02-28 Common Stock F 38.5686 $45.3500 Disposed 24711.4023 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4554.9879 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.